13F Holdings
中文EN

HYEX HEALTHY EXTRACTS INC.

Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1630176 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY66.9%
TTM net income YoY-87.1%
TTM EPS YoY—
Revenue 3-yr CAGR31.5%
Net income 3-yr CAGR—

Margins

Gross margin62.4%
Operating margin—
Net margin-36.7%
FCF margin—
EBITDA margin—

Returns

ROE-9.7%
ROA-7.5%
ROIC (approx.)—
Asset turnover0.21x

Leverage & solvency

Liabilities / assets34.0%
Debt / equity0.00x
Current ratio0.14x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.33x
Accruals ratio-10.0%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$4.51M$3.11M$2.49M$2.25M$1.68M
Cost of revenue$2.09M$1.20M$864,055$879,951$981,520
Gross profit$2.42M$1.91M$1.62M$1.37M$695,078
SG&A expense$3.37M$2.09M$3.87M$2.28M$2.58M
Income tax$0$0$0$0—
Net income-$881,119-$840,671-$2.47M-$983,121-$1.99M
EPS (diluted)—————
Banking
Net interest income-$210,279-$186,252-$176,948-$64,690-$52,453
Balance sheet
Cash & equivalents$146,935$112,020$19,441$65,651$222,098
Receivables$187,750$11,003$30,440$105,794$133,340
Inventory$843,357$1.36M$1.63M$1.82M$1.96M
Current assets$1.33M$1.66M$1.90M$2.04M$2.31M
Goodwill$21.12M$193,260$193,260$193,260$193,260
Intangibles$4.23M$3,445$3,306$5,501$1,035
Total assets$27.82M$2.38M$2.64M$2.78M$3.03M
Current liabilities$1.76M$1.34M$1.68M$902,788$558,841
Total liabilities$3.80M$1.97M$1.68M$909,602$558,841
Shareholders' equity$24.03M$410,377$954,590$1.87M$2.47M
Shares outstanding16.87M2.99M2.95M2.88M338.38M
Cash flow statement
Operating cash flow$165,520$281,968-$415,749-$390,621-$901,298
Capital expenditure——$0$7,987$0
Free cash flow——-$415,749-$398,608-$901,298
Investing cash flow$56,301$0$0-$5,344-$96,004
Financing cash flow-$186,906-$189,389$369,539$239,518$1.16M
Depreciation & amortization————$5,100
Stock-based compensation———$0$0

Free plan shows the latest 5 periods; Pro shows all 11 🔒

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.